{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:30:10Z","timestamp":1793331010964,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00520-014-2531-6","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T13:34:41Z","timestamp":1417527281000},"page":"1759-1767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study"],"prefix":"10.1007","volume":"23","author":[{"given":"H.","family":"Bozcuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arta\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7.","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ulukal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"K\u0131l\u0131\u00e7kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Savas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,30]]},"reference":[{"key":"2531_CR1","first-page":"CD007107","volume":"1","author":"C Herbst","year":"2009","unstructured":"Herbst C, Naumann F, Kruse EB et al (2009) Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane Database Syst Rev 1:CD007107","journal-title":"Cochrane Database Syst Rev"},{"key":"2531_CR2","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","volume":"42","author":"MS Aapro","year":"2006","unstructured":"Aapro MS, Cameron DA, Pettengell R et al (2006) European organisation for research and treatment of cancer (EORTC) granulocyte colony-stimulating factor (G-CSF) guidelines working party. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42:2433\u20132453","journal-title":"Eur J Cancer"},{"key":"2531_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605269","volume":"101","author":"S Kelly","year":"2009","unstructured":"Kelly S, Wheatley D (2009) Prevention of febrile neutropenia: use of granulocyte colony stimulating factors. Br J Cancer 101:6\u201310","journal-title":"Br J Cancer"},{"key":"2531_CR4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00520-010-0816-y","volume":"18","author":"M Aapro","year":"2010","unstructured":"Aapro M, Crawford J, Didier K (2010) Prophylaxis of chemotherapy induced febrile neutropenia with granulocyte colony stimulating factors: where are we know? Support Care Cancer 18:549\u2013541","journal-title":"Support Care Cancer"},{"issue":"9","key":"2531_CR5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"JY Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, De Lena M et al (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7(9):719\u2013727","journal-title":"Lancet Oncol"},{"key":"2531_CR6","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","volume":"23","author":"M Marty","year":"2005","unstructured":"Marty M, Cognetti F, Maraninchi D et al (2005) Randomised phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with epidermal growth factor receptor-2 positive metastatic breast cancer administered as first line treatment. The M77001 Study Group. J Clin Oncol 23:4265\u20134274","journal-title":"J Clin Oncol"},{"key":"2531_CR7","unstructured":"NCCN Guidelines. Myeloid growth factors. Version 1 (2013) ( http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/myeloid_growth.pdf )"},{"issue":"19","key":"2531_CR8","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH et al (2006) 2006 update of the recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19):3187\u20133205","journal-title":"J Clin Oncol"},{"key":"2531_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1634\/theoncologist.10-6-427","volume":"10","author":"GH Lynman","year":"2005","unstructured":"Lynman GH, Lynman CH, Agboola O (2005) Risk models for chemotherapy-induced neutropenia. Oncologist 10:427\u2013437","journal-title":"Oncologist"},{"key":"2531_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/COC.0b013e318165c01d","volume":"31","author":"G Dranisatris","year":"2008","unstructured":"Dranisatris G, Rayson D, Vincent M et al (2008) Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model. Am J Clin Oncol 31:369\u2013374","journal-title":"Am J Clin Oncol"},{"key":"2531_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2008.07514.x","volume":"144","author":"R Pettengell","year":"2009","unstructured":"Pettengell R, Bosly A, Szucs TD et al (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU prospective observational European Neutropenia Study. Br J Haematol 144:677\u2013685","journal-title":"Br J Haematol"},{"key":"2531_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/annonc\/mdm541","volume":"19","author":"M Ziepert","year":"2008","unstructured":"Ziepert M, Schmits R, Trumper L et al (2008) Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol 19:752\u2013762","journal-title":"Ann Oncol"},{"key":"2531_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3816\/SCT.2003.n.002","volume":"1","author":"GH Lynman","year":"2003","unstructured":"Lynman GH, Kuderer NM (2003) Epidemiology of febrile neutropenia. Support Cancer Ther 1:23\u201335","journal-title":"Support Cancer Ther"},{"key":"2531_CR14","doi-asserted-by":"crossref","unstructured":"Morrison VA, Caggiano V, Fridman M et al. (2004) A model to predict chemotherapy-related severe or febrile neutropenia in cycle one among breast cancer or lymphoma patients. Proc Am Soc Clin Oncol 23 (abstr 742)","DOI":"10.1200\/jco.2004.22.90140.8068"},{"key":"2531_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjc.6600724","volume":"88","author":"I Ray-Coquard","year":"2003","unstructured":"Ray-Coquard I, Borg C, Bachelot T et al (2003) Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer 88:181\u2013186","journal-title":"Br J Cancer"},{"key":"2531_CR16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","volume":"14","author":"JY Blay","year":"1996","unstructured":"Blay JY, Chauvin F, Le Cesne A et al (1996) Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 14:636\u2013643","journal-title":"J Clin Oncol"},{"key":"2531_CR17","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.1998.16.6.2065","volume":"16","author":"H Gomez","year":"1986","unstructured":"Gomez H, Hidalgo M, Casanova L et al (1986) Risk factors for treatment-related death in early patients with aggressive non-Hodgkin\u2019s lymphoma: results of a multivariate analysis. J Clin Oncol 16:2065\u20132069","journal-title":"J Clin Oncol"},{"key":"2531_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","volume":"100","author":"J Crawford","year":"2004","unstructured":"Crawford J, Dale DC, Lyman GH (2004) Chemotherapy induced neutropenia. Cancer 100:228\u2013237","journal-title":"Cancer"},{"key":"2531_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2007.01.008","volume":"53","author":"C Gridelli","year":"2007","unstructured":"Gridelli C, Aapro MS, Barni S et al (2007) Role of colony stimulating factors in solid tumors: results of an expert panel. Crit Rev Oncol Hematol 53:53\u201364","journal-title":"Crit Rev Oncol Hematol"},{"key":"2531_CR20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ncpuro0968","volume":"4","author":"MW Kattan","year":"2007","unstructured":"Kattan MW, Scardino PT (2007) Evidence for the usefulness of nomograms. Nat Clin Pract Urol 4:638\u2013639","journal-title":"Nat Clin Pract Urol"},{"issue":"6","key":"2531_CR21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.urology.2010.06.019","volume":"76","author":"JV Andrews","year":"2010","unstructured":"Andrews JV, Cronin AM (2010) Everything you always wanted to know about evaluating prediction models. Urology 76(6):1298\u20131301","journal-title":"Urology"},{"key":"2531_CR22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasanos","year":"2008","unstructured":"Iasanos A, Schrag D, Raj GV, Panageas K (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364\u20131370","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2531-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2531-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T17:58:14Z","timestamp":1650736694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2531-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,30]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2531-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,30]]}}}